Skip to content
Insights & Resources

Data-Driven Insights for B2B & B2C Growth

Expert perspectives on brand building, marketing operations, revenue alignment, and growth strategies that work.

Showing 10 of 36 articles

Pharma & Biotech

How AI Is Changing Clinical Trial Design in 2025

A CMO reviews a Phase 2 protocol. The team has designed a traditional randomized, double-blind, placebo-controlled trial with a fixed…

Hamza
8 min
Pharma & Biotech

China Biotech Licensing Wave: What It Means for Western BD Teams

In 2023, Chinese biotechs signed over $50 billion in total deal value with Western pharma companies. By mid-2024, that pace…

Hamza
8 min
Pharma & Biotech

Decentralized Clinical Trials: Benefits, Limitations and When to Use Them

During the pandemic, a Phase 3 trial for a cardiovascular drug shifted from 100% site-based visits to a hybrid model…

Hamza
8 min
Pharma & Biotech

Senior Living Market Overview 2025: Occupancy, Supply and Demand

After three years of pandemic recovery, the senior living market in 2025 has reached an inflection point. National occupancy rates…

Hamza
8 min
Pharma & Biotech

HTA Systems Compared: NICE, G-BA, HAS, AIFA – How They Differ

A market access team prepares an HTA submission for a new oncology drug. They build a dossier with strong clinical…

Hamza
8 min
Drug Patent Basics: What Every BD and Strategy Professional Needs to Know
Pharma & Biotech

Drug Patent Basics: What Every BD and Strategy Professional Needs to Know

Drug patents are among the most misunderstood aspects of pharmaceutical business development. A compound may be described as “protected until…

Hamza
11 min
Clinical Trial Failure Rates: What R&D Leaders Need to Know
Pharma & Biotech

Clinical Trial Failure Rates: What R&D Leaders Need to Know

Clinical trial failure rates remain one of the most important metrics in pharmaceutical R&D. Understanding clinical trial failure rates helps…

Hamza
10 min
Pharma & Biotech

The Complete Glossary of Drug Development Stages for Non-Scientists

You join a pharma company’s strategy team. In your first week, a colleague says: “The target has a Phase 2b…

Hamza
9 min
Pharma & Biotech

What Is Agetech and Why It’s One of the Fastest-Growing Investment Themes of 2025

By 2030, every Baby Boomer in the United States will be over 65. Globally, the 65+ population will exceed 1…

Hamza
8 min

Get Weekly Growth Insights

Join 200+ marketers getting actionable strategies every Tuesday.

Subscribe

No spam. Unsubscribe anytime.